Sulfonylurea derivatives and uses thereof
US12054461B2 · kind B2 · utility
0Cited by
24References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2020 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Sep 13, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of Formula (I) and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.